tirzepatide for obesity fda approval Zepbound (tirzepatide) injection, the first and only treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA approves tirzepatide (Zepbound) injection

Dual receptor activation (GHRH-R + GHS-R1a) produces synergistic GH pulses that exceed either compound alone while still preserving pulsatility

With over 10 years of experience in the medical field, Susan brings knowledge, compassion, and dedication to every patient interaction

The result is bigger A1C reductions and more weight loss than either drug alone

If you have had a particularly demanding day or have been losing sleep, an evening dose can support these restorative pathways, which fits well within the Healthy Aging Supplements range

This investment is one of the most significant milestones for Corxel since its founding as it not only fuels our effort to accelerate the global development of industry-leading therapies against cardiometabolic diseases but also propels the company to a new orbit of growth. Sandy Mou, CEO of Corxel, said at the time